Cipla Ltd CIPLA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/03/21 IST
812.50UNCH (UNCH)
52 week range
354.38 - 878.90

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close812.50
  • 52 Week High878.90
  • 52 Week High Date02/03/21
  • 52 Week Low354.38
  • 52 Week Low Date03/13/20
  • Market Cap8,599.51M
  • Shares Out806.37M
  • 10 Day Average Volume3.89M
  • Dividend4.50
  • Dividend Yield0.55%
  • Beta
  • 1 Year % Change91.4

RATIOS/PROFITABILITY

  • EPS (TTM)27.75
  • P/E (TTM)29.28
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/19/2020
  • Div Amount1.00
  • Split Date-
  • Split Factor-

Latest Cipla Ltd News

There is no recent news for this security.

Latest CIPLA-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based...
Samina Hamied
Vice Chairman
Yusuf Hamied
Non-Executive Chairman
Umang Vohra
Chief Executive Officer
Kedar Upadhye
Chief Financial Officer
Geena Malhotra
Chief Technology Officer
Address
Mumbai Central
Mumbai
400013
India